1.070000 EUR
0.1
8.55%
Last update Dec 15, 7:31 PM CET
Main market
Day range
1.040000
1.22000
Previous close
1.17000
Open
1.21000
Access this stock data via API
Subscribe
InMed Pharmaceuticals Inc.
1.07
0.10
8.55%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2025 2024 2023 2022
Total reported revenue 4.2M 3.9M 6.0M 1.6M
Cost of revenue 2.8M 3.0M 3.9M 787.0K
Gross profit 1.5M 940.3K 2.0M 783.6K
Operating expense
Research & development 2.4M 3.2M 5.4M 10.5M
Selling general and admin 5.6M 4.5M 8.4M 9.9M
Other operating expenses
Operating income -6.7M -6.9M -12.1M -19.9M
Non operating interest income
Income 132.9K 450.9K 710.0K 138.5K
Expense 316.7K 0
Other income expense -24.3K -52.9K -69.5K -7.1M
Pretax income -7.0M -6.5M -11.4M -26.8M
Tax provision 0 6.1K 18.9K 0
Net income -7.0M -6.6M -11.5M -26.8M
Basic EPS -8.4 -20.2 -65 -663.4
Diluted EPS -8.4 -20.2 -65 -663.4
Basic average shares 831.8K 325.5K 186.1K 42.6K
Diluted average shares 831.8K 325.5K 186.1K 42.6K
EBITDA -6.2M -6.4M -11.2M -12.1M
Net income from continuing op. -7.0M -6.6M -11.5M -26.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 8 hours 3 minutes

11:56
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).